<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28807" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Sebaceous Gland Carcinoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gall</surname>
            <given-names>Ryan</given-names>
          </name>
          <aff>NCC</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ortiz-Perez</surname>
            <given-names>Santiago</given-names>
          </name>
          <aff>University Hospital Virgen de las Nieves</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ryan Gall declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Santiago Ortiz-Perez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28807.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Sebaceous carcinomas are rare malignant tumors of the sebaceous glands. They most commonly develop on the eyelid, but may arise from anywhere sebaceous glands are present. These tumors may arise spontaneously or in association with Muir-Torre syndrome. This activity reviews the diagnosis, evaluation, and treatment of sebaceous carcinomas and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of sebaceous carcinomas.</p></list-item><list-item><p>Review the process for the evaluation of sebaceous carcinomas.</p></list-item><list-item><p>Outline the management options available for sebaceous carcinomas.</p></list-item><list-item><p>Describe interprofessional team strategies for improving care coordination and communication to advance sebaceous carcinoma treatment and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28807&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28807">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-28807.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Sebaceous carcinoma (SC) is a rare and aggressive malignancy that develops from the sebaceous glands. Sebaceous carcinoma is most common in the periocular area, head, and neck, but can occur anywhere in the body where sebaceous glands are present.<xref ref-type="bibr" rid="article-28807.r1">[1]</xref>&#x000a0;</p>
        <p>Sebaceous carcinomas may behave as primary neoplasms&#x000a0;or may&#x000a0;occur in association with Muir-Torre syndrome (a form of Lynch syndrome&#x000a0;characterized by sebaceous tumors and other&#x000a0;internal cancers, being the most common those affecting the&#x000a0;gastrointestinal tract). SC behaves aggressively both locally and distantly; locally, it correlates with a multifocal origin, and causes destruction and sometimes a pattern of pagetoid spread, which is challenging to diagnose. Moreover, this tumor easily causes distant metastasis. For those reasons, the SC is considered an aggressive disease, which causes significant morbidity and mortality.&#x000a0;</p>
      </sec>
      <sec id="article-28807.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>As mentioned above, SC has its origin in sebaceous cells. When occurring in the periocular region, the most frequent, SC&#x000a0;usually arise from Meibomian glands, which are modified sebaceous glands, but also from the sebaceous glands of Zeiss, and the sebaceous glands&#x000a0;in the ocular caruncle.<xref ref-type="bibr" rid="article-28807.r2">[2]</xref>&#x000a0;</p>
        <p>The majority of sebaceous carcinomas arise from de novo mutations. They may also develop from benign sebaceous neoplasms, although this appears to be relatively uncommon. Sebaceous carcinomas associated with Muir-Torre syndrome have a loss of mismatch repair gene expression and exhibit microsatellite instability.<xref ref-type="bibr" rid="article-28807.r3">[3]</xref>&#x000a0;Sebaceous carcinomas that occur sporadically do not exhibit loss of mismatch repair or microsatellite instability.<xref ref-type="bibr" rid="article-28807.r4">[4]</xref></p>
      </sec>
      <sec id="article-28807.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>SC is more frequent in older women. It is a rare malignancy in White race individuals, whereas in the Asian population represents up to 28% of all lid malignancies. Overall, SC&#x000a0;has an estimated incidence of approximately 1&#x000a0;to 2 cases per 1,000,000 person-years.<xref ref-type="bibr" rid="article-28807.r5">[5]</xref><xref ref-type="bibr" rid="article-28807.r6">[6]</xref>&#x000a0;More than 98% of SC&#x000a0;occurs in patients over the age of 40, and the peak incidence occurs in the seventh and eighth decades of life.<xref ref-type="bibr" rid="article-28807.r7">[7]</xref>&#x000a0;There&#x000a0;have only been reports of it appearing in a handful of childhood cases.<xref ref-type="bibr" rid="article-28807.r8">[8]</xref>&#x000a0;Sebaceous carcinoma is approximately three times as common in whites as in non-White patients. Regarding the anatomy, these tumors are more frequent in the upper eyelid, as there are more meibomian glands there.<xref ref-type="bibr" rid="article-28807.r9">[9]</xref><xref ref-type="bibr" rid="article-28807.r7">[7]</xref>&#x000a0;</p>
        <p>Risk factors for the development of sebaceous carcinoma include prior radiation exposure, immunosuppression, and Muir-Torre syndrome.</p>
      </sec>
      <sec id="article-28807.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histopathology typically shows irregular, asymmetric sebaceous lobules within the dermis. Malignant cells show significant amounts of pleomorphism, hyperchromatism, mitotic activity, and nuclear atypia. Lesions may be classified as poorly, moderately, or well-differentiated (see <bold>Images.</bold> Sebaceous Carcinoma, Low-Power Field; Sebaceous Carcinoma, High-Power Field). Well-differentiated lesions may demonstrate foamy cytoplasm, comedo-necrosis, and pagetoid spread.<xref ref-type="bibr" rid="article-28807.r10">[10]</xref> Sebaceous carcinomas fall into four histopathologic categories: papillary, lobular, comedocarcinoma, and mixed.<xref ref-type="bibr" rid="article-28807.r11">[11]</xref>&#x000a0;Immunohistochemical stains for sebaceous carcinoma include adipophilin, EMA, androgen receptor, and nuclear factor XIIIa.<xref ref-type="bibr" rid="article-28807.r12">[12]</xref><xref ref-type="bibr" rid="article-28807.r13">[13]</xref>&#x000a0;Adipophilin in a vesicular instead of granular staining pattern and nuclear factor XIIIa are the most specific and sensitive among the stains.<xref ref-type="bibr" rid="article-28807.r13">[13]</xref><xref ref-type="bibr" rid="article-28807.r14">[14]</xref><xref ref-type="bibr" rid="article-28807.r15">[15]</xref>&#x000a0;Negative staining for S100 and HMB-45 may help differentiate sebaceous carcinoma from balloon cell or amelanotic melanoma.<xref ref-type="bibr" rid="article-28807.r10">[10]</xref></p>
      </sec>
      <sec id="article-28807.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Approximately 40% of all sebaceous carcinomas present on the eyelids, with 80% occurring on the head or neck.<xref ref-type="bibr" rid="article-28807.r1">[1]</xref>&#x000a0;On the eyelid, sebaceous carcinomas typically develop as a firm, round, enlarging nodule. They are two to three times more frequent in the upper lid due to the more number of sebaceous glands there. SC&#x000a0;may also present with inflammation and thickening of the eyelid, typically mimicking other conditions, especially chalazion and blepharitis, and even conjunctivitis, and causing a delayed diagnosis. Local spread is frequent and may lead to involve wide areas of the conjunctiva and even the cornea. Advanced infiltration may cause&#x000a0;invasion of the orbit and adjacent periorbital structures.</p>
        <p>SC&#x000a0;of extra-ocular locations generally presents as a yellowish nodule, often with ulceration. The head and neck are the most common locations; however, the trunk and extremities may also have involvement. There are also rare reports of cases of SC&#x000a0;development at extracutaneous sites, such as the parotid gland, breast, ovary, and prostate.<xref ref-type="bibr" rid="article-28807.r16">[16]</xref></p>
      </sec>
      <sec id="article-28807.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>SC must always be in mind when treating a patient with unilateral resistant blepharoconjunctivitis, or a chalazion or stye that does not resolve or recur after treatment. An incisional biopsy might be necessary to confirm the diagnosis. Excisional biopsy with wide margins is considered the gold standard treatment, which is also useful to confirm the diagnosis. Routine histologic staining with hematoxylin and eosin will generally provide a diagnosis and is useful for staging of the lesion. Immunohistochemistry may also be useful to confirm the diagnosis and to differentiate from other non-melanoma skin cancers. Sebaceous carcinomas can exhibit nearly 100% EMA, ADP, and AR positivity.<xref ref-type="bibr" rid="article-28807.r12">[12]</xref><xref ref-type="bibr" rid="article-28807.r14">[14]</xref><xref ref-type="bibr" rid="article-28807.r17">[17]</xref>&#x000a0;</p>
        <p>While the majority of sebaceous carcinomas occur sporadically, some&#x000a0;experts recommend screening all patients with this diagnosis for Muir-Torre syndrome.</p>
        <p>A comprehensive physical exam to assess the globe and the periocular region for disease, as well as palpation of the preauricular and cervical areas for enlarged lymph nodes, should be performed. If the eyelid lesion appears to be diffuse or if there is any evidence of lymphadenopathy, then head and neck&#x000a0;or even systemic imaging are warranted to evaluate the degree of&#x000a0;disease spread. Fine-needle aspiration biopsy of suspicious lymph nodes can help diagnose sebaceous carcinoma.</p>
      </sec>
      <sec id="article-28807.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The primary goal of treatment is complete surgical excision of the tumor. Wide local excision with the use of frozen sections, or Mohs micrographic surgery, are first-line treatments for sebaceous carcinoma of the head or neck.<xref ref-type="bibr" rid="article-28807.r18">[18]</xref><xref ref-type="bibr" rid="article-28807.r1">[1]</xref>&#x000a0;If conjunctival epithelial involvement is identified, treatment may involve cryotherapy, surgical resection of the affected bulbar epithelium, or use of topical mitomycin C.<xref ref-type="bibr" rid="article-28807.r19">[19]</xref>&#x000a0;In cases where surgical resection is not possible, mainly in cases of extensive conjunctival spread or orbital extension, orbital exenteration is often required.&#x000a0;</p>
        <p>&#x000a0;The role of radiation therapy for primary sebaceous carcinomas is uncertain.&#x000a0;Some small studies have reported good outcomes from the use of radiation as the primary treatment of ocular sebaceous carcinoma, but surgical resection remains the primary treatment modality.<xref ref-type="bibr" rid="article-28807.r20">[20]</xref><xref ref-type="bibr" rid="article-28807.r21">[21]</xref></p>
        <p>Adjuvant therapies include cryotherapy, and topical mitomycin C. The use of these therapies is primarily reserved for pagetoid spread to the conjunctiva.&#x000a0;</p>
      </sec>
      <sec id="article-28807.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Several benign and malignant conditions merit consideration in the differential diagnosis for SC. These tumors&#x000a0;may often mimic a chalazion, especially if they become painful or inflamed, resistant to the usual treatment, or if they recur after surgery. An extensive list of eyelid masses may be part of the differential diagnosis of SC, including apart from the most frequent chalazion, other tumors such us inclusion cyst, papilloma, keratosis, keratoacanthoma, or dermoid cyst, among others.<xref ref-type="bibr" rid="article-28807.r22">[22]</xref>&#x000a0;</p>
        <p>Benign sebaceous neoplasms such as sebaceous adenomas may present similarly to SC, but these benign lesions are uncommon in the periocular region.<xref ref-type="bibr" rid="article-28807.r23">[23]</xref>&#x000a0;Basal cell carcinomas, squamous cell carcinomas, and Merkel cell carcinomas may all have clinical presentations similar to SC; the histologic examination is essential for differentiating these.&#x000a0;</p>
      </sec>
      <sec id="article-28807.s10" sec-type="Staging">
        <title>Staging</title>
        <p>Evaluation for evidence of local tumor spread should be performed immediately after diagnosis. Regional lymph nodes should be palpated for evidence of metastasis, with a biopsy performed on concerning lymph nodes. Ophthalmologists usually diagnose patients diagnosed with SC of the eyelids; a comprehensive ophthalmic examination is mandatory to assess for the clinical tumor extension.</p>
        <p>There is no clear consensus and guidelines concerning the systemic evaluation of these patients; however, patients with large tumors, or those where there has been delayed diagnosis, should undergo imaging with CT or MRI to evaluate for a distant extension. Patients with Muir-Torre may also receive benefits from a PET scan for early detection of visceral malignancies.<xref ref-type="bibr" rid="article-28807.r24">[24]</xref></p>
      </sec>
      <sec id="article-28807.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Sebaceous carcinomas tend to be aggressive with significant potential for nodal and distant metastasis. Ocular sebaceous carcinomas have demonstrated a recurrence rate of 11&#x000a0;to 30% after excision and a rate of metastasis of 25%.<xref ref-type="bibr" rid="article-28807.r25">[25]</xref>&#x000a0;For extraocular sebaceous carcinoma, rates of recurrence and distant metastases are 29% and 21%, respectively.<xref ref-type="bibr" rid="article-28807.r1">[1]</xref>&#x000a0;</p>
        <p>Regional lymph nodes are the most common sites of spread; lungs, brain, liver, small intestine, and urinary tract metastasis have also been reported. Overall mortality rates are between 9 and 50%.<xref ref-type="bibr" rid="article-28807.r1">[1]</xref>&#x000a0;Five-year survival rates are more favorable for the ocular disease at 75.2%, compared to the extraocular disease at 68%.<xref ref-type="bibr" rid="article-28807.r26">[26]</xref>&#x000a0;Negative prognostic factors include size greater than 1 cm, poor differentiation on histopathology, lymphovascular invasion, and lesions involving both the upper and lower eyelid.</p>
      </sec>
      <sec id="article-28807.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Recurrence, local invasion, and distant metastasis by lymphatic or hematogenous spread are all relatively common complications of sebaceous carcinoma.&#x000a0;</p>
      </sec>
      <sec id="article-28807.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>No known modifiable risk factors for the development of sebaceous carcinoma exist. Patients with a diagnosis of Muir-Torre should receive education regarding the risk of sebaceous carcinoma, and to seek medical care if a concerning skin lesion develops. Also, patients with chronic inflammatory processes of the eye and eyelids should attend an ophthalmologist for an examination.</p>
      </sec>
      <sec id="article-28807.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Sebaceous gland carcinoma is a rare tumor that masquerades as benign ocular conditions and hence requires the clinicians to work in a multidisciplinary team to identify the tumor, make a correct pathological diagnosis, and perform an&#x000a0;early surgical therapy trying to cure the disease. Delayed management of these cases might be fatal due to the aggressive nature of the tumor. Whenever sebaceous tumors are identified, clinicians should consider internal malignancies.</p>
        <p>Early recognition aids in the prompt treatment of patients and screening of family members for early intervention. Many health professionals may be involved in the care of patients affected with SC, such as physicians&#x000a0;and surgeons of different specialties (depending on the location of the tumor), radiologists, pathologists, and nurses.</p>
        <p>Disclosure: The views expressed in this article are those of the author and do not reflect the official policy of the Departments of Navy/ Army/ or Air Force, Department of Defense, or US Government.</p>
      </sec>
      <sec id="article-28807.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28807&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28807">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/sebaceous-gland-carcinoma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=28807">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28807/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28807">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-28807.s16">
        <fig id="article-28807.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Sebaceous Carcinoma, Low-Power Field Contributed by Dipti Anand, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Sebaceous__ca" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-28807.s17">
        <fig id="article-28807.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Sebaceous Carcinoma, High-Power Field Contributed by Dipti Anand, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="seb__carcinoma__2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-28807.s18">
        <title>References</title>
        <ref id="article-28807.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dasgupta</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>A retrospective review of 1349 cases of sebaceous carcinoma.</article-title>
            <source>Cancer</source>
            <year>2009</year>
            <month>Jan</month>
            <day>01</day>
            <volume>115</volume>
            <issue>1</issue>
            <fpage>158</fpage>
            <page-range>158-65</page-range>
            <pub-id pub-id-type="pmid">18988294</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salazar-Villegas</surname>
                <given-names>&#x000c1;</given-names>
              </name>
              <name>
                <surname>Matas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Palma-Carvajal</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Valdivia</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Alos</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ortiz-P&#x000e9;rez</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Sebaceous carcinoma of the caruncle.</article-title>
            <source>J Fr Ophtalmol</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>42</volume>
            <issue>8</issue>
            <fpage>925</fpage>
            <page-range>925-927</page-range>
            <pub-id pub-id-type="pmid">31178073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kraft</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Granter</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Molecular pathology of skin neoplasms of the head and neck.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>138</volume>
            <issue>6</issue>
            <fpage>759</fpage>
            <page-range>759-87</page-range>
            <pub-id pub-id-type="pmid">24878016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rajan Kd</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Burris</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Iliff</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Grant</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eshleman</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Eberhart</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>157</volume>
            <issue>3</issue>
            <fpage>640</fpage>
            <page-range>640-7.e1-2</page-range>
            <pub-id pub-id-type="pmid">24321472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuzel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Metelitsa</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Dover</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Salopek</surname>
                <given-names>TG</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of sebaceous carcinoma in Alberta, Canada, from 1988 to 2007.</article-title>
            <source>J Cutan Med Surg</source>
            <year>2012</year>
            <season>Nov-Dec</season>
            <volume>16</volume>
            <issue>6</issue>
            <fpage>417</fpage>
            <page-range>417-23</page-range>
            <pub-id pub-id-type="pmid">23149197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dores</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Toro</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Devesa</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Fraumeni</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome.</article-title>
            <source>Cancer</source>
            <year>2008</year>
            <month>Dec</month>
            <day>15</day>
            <volume>113</volume>
            <issue>12</issue>
            <fpage>3372</fpage>
            <page-range>3372-81</page-range>
            <pub-id pub-id-type="pmid">18932259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bordeaux</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Incidence and survival of sebaceous carcinoma in the United States.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>75</volume>
            <issue>6</issue>
            <fpage>1210</fpage>
            <page-range>1210-1215</page-range>
            <pub-id pub-id-type="pmid">27720512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Omura</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Collison</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Sebaceous carcinoma in children.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2002</year>
            <month>Dec</month>
            <volume>47</volume>
            <issue>6</issue>
            <fpage>950</fpage>
            <page-range>950-3</page-range>
            <pub-id pub-id-type="pmid">12451386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rao</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Hidayat</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>McLean</surname>
                <given-names>IW</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Sebaceous carcinomas of the ocular adnexa: A clinicopathologic study of 104 cases, with five-year follow-up data.</article-title>
            <source>Hum Pathol</source>
            <year>1982</year>
            <month>Feb</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>113</fpage>
            <page-range>113-22</page-range>
            <pub-id pub-id-type="pmid">7076199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nelson</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Hamlet</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Gillard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Railan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Sebaceous carcinoma.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1995</year>
            <month>Jul</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-15; quiz 16-8</page-range>
            <pub-id pub-id-type="pmid">7601925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jakobiec</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Mendoza</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>157</volume>
            <issue>1</issue>
            <fpage>186</fpage>
            <page-range>186-208.e2</page-range>
            <pub-id pub-id-type="pmid">24112633</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mulay</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Honavar</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor).</article-title>
            <source>Can J Ophthalmol</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>49</volume>
            <issue>4</issue>
            <fpage>326</fpage>
            <page-range>326-32</page-range>
            <pub-id pub-id-type="pmid">25103648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uhlenhake</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Smoller</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Shalin</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Gardner</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a sensitive and specific marker to discriminate sebaceous proliferations from other cutaneous clear cell neoplasms.</article-title>
            <source>J Cutan Pathol</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>43</volume>
            <issue>8</issue>
            <fpage>649</fpage>
            <page-range>649-56</page-range>
            <pub-id pub-id-type="pmid">27153339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ansai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Takeichi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Arase</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kawana</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Sebaceous carcinoma: an immunohistochemical reappraisal.</article-title>
            <source>Am J Dermatopathol</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>579</fpage>
            <page-range>579-87</page-range>
            <pub-id pub-id-type="pmid">21778832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ostler</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Prieto</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Reed</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Deavers</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Lazar</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Ivan</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: an immunohistochemical study of 117 cases.</article-title>
            <source>Mod Pathol</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>567</fpage>
            <page-range>567-73</page-range>
            <pub-id pub-id-type="pmid">20118912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gnepp</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>My journey into the world of salivary gland sebaceous neoplasms.</article-title>
            <source>Head Neck Pathol</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>101</fpage>
            <page-range>101-10</page-range>
            <pub-id pub-id-type="pmid">22430772</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Plaza</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Mackinnon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carrillo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Prieto</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Sangueza</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Suster</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.</article-title>
            <source>Am J Dermatopathol</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>37</volume>
            <issue>11</issue>
            <fpage>809</fpage>
            <page-range>809-21</page-range>
            <pub-id pub-id-type="pmid">26485238</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hou</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Killian</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Baum</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Otley</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Roenigk</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Arpey</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Weaver</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Brewer</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Characteristics of sebaceous carcinoma and early outcomes of treatment using Mohs micrographic surgery versus wide local excision: an update of the Mayo Clinic experience over the past 2 decades.</article-title>
            <source>Dermatol Surg</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>40</volume>
            <issue>3</issue>
            <fpage>241</fpage>
            <page-range>241-6</page-range>
            <pub-id pub-id-type="pmid">24460730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Demirci</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Marr</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Stefanyszyn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Conjunctival epithelial involvement by eyelid sebaceous carcinoma. The 2003 J. Howard Stokes lecture.</article-title>
            <source>Ophthalmic Plast Reconstr Surg</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>92</fpage>
            <page-range>92-6</page-range>
            <pub-id pub-id-type="pmid">15778660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Azad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Choudhary</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Treatment results of high dose rate interstitial brachytherapy in carcinoma of eye lid.</article-title>
            <source>J Cancer Res Ther</source>
            <year>2011</year>
            <season>Apr-Jun</season>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>157</fpage>
            <page-range>157-61</page-range>
            <pub-id pub-id-type="pmid">21768703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Koike</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Maegawa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kaneko</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Odagiri</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kasuya</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Minagawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kaizu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mukai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Radiation therapy for primary carcinoma of the eyelid: tumor control and visual function.</article-title>
            <source>Strahlenther Onkol</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>188</volume>
            <issue>12</issue>
            <fpage>1102</fpage>
            <page-range>1102-7</page-range>
            <pub-id pub-id-type="pmid">23104519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wali</surname>
                <given-names>UK</given-names>
              </name>
              <name>
                <surname>Al-Mujaini</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Sebaceous gland carcinoma of the eyelid.</article-title>
            <source>Oman J Ophthalmol</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>117</fpage>
            <page-range>117-21</page-range>
            <pub-id pub-id-type="pmid">21120046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Demirci</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Marr</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Sebaceous carcinoma of the eyelids: personal experience with 60 cases.</article-title>
            <source>Ophthalmology</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>111</volume>
            <issue>12</issue>
            <fpage>2151</fpage>
            <page-range>2151-7</page-range>
            <pub-id pub-id-type="pmid">15582067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ishiguro</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Homma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ohno</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ichikawa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kawamura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hata</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kase</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ishida</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Okada-Kanno</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hatanaka</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Taketomi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Usefulness of PET/CT for early detection of internal malignancies in patients with Muir-Torre syndrome: report of two cases.</article-title>
            <source>Surg Case Rep</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <pub-id pub-id-type="pmid">28537014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watanabe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Pirbhai</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ueda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Katori</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Selva</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Sebaceous carcinoma in Japanese patients: clinical presentation, staging and outcomes.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>97</volume>
            <issue>11</issue>
            <fpage>1459</fpage>
            <page-range>1459-63</page-range>
            <pub-id pub-id-type="pmid">24037608</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28807.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Snow</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Larson</surname>
                <given-names>PO</given-names>
              </name>
              <name>
                <surname>Lucarelli</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Lemke</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Madjar</surname>
                <given-names>DD</given-names>
              </name>
            </person-group>
            <article-title>Sebaceous carcinoma of the eyelids treated by mohs micrographic surgery: report of nine cases with review of the literature.</article-title>
            <source>Dermatol Surg</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>28</volume>
            <issue>7</issue>
            <fpage>623</fpage>
            <page-range>623-31</page-range>
            <pub-id pub-id-type="pmid">12135523</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
